<?xml version="1.0" encoding="UTF-8"?>
<document id="29293945">
	<sentence id="s1" text="We aimed to test effects of such gCNVs on the risk of lung cancer and chronic obstructive pulmonary disease (ER to Golgi vesicle-mediated transport).">
		<entity id="s1.e1" charOffset="59-65"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="109-147"
			type="GO" text="ER to Golgi vesicle-mediated transport" ontology_id="GO_0006888"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Genomic imbalance of lung cancer was determined by the array comparative genomic hybridization (aCGH), and common gCNVs at these imbalance regions were genotyped in lung cancer-based and ER to Golgi vesicle-mediated transport-based retrospective studies.">
		<entity id="s2.e1" charOffset="26-32"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s2.e2" charOffset="187-225"
			type="GO" text="ER to Golgi vesicle-mediated transport" ontology_id="GO_0006888"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="The CNVR_3425.1, overlapping the chr16q24.1 with genomic imbalance, was significantly associated with increased risks of lung cancer (OR = 1.76; 95% CI = 1.46-2.11) and ER to Golgi vesicle-mediated transport (OR = 1.98; 95% CI = 1.57-2.51).">
		<entity id="s3.e1" charOffset="126-132"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s3.e2" charOffset="169-207"
			type="GO" text="ER to Golgi vesicle-mediated transport" ontology_id="GO_0006888"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
	<sentence id="s4" text="The increase copy of CNVR_3425.1 forms a new additional truncated positive regulation of transcription, DNA-templated adjacent non-coding developmental regulatory RNA (FENDRR) sequences comparing the gene promoter and perturbs the transcriptional factors (TFs) binding to the original FENDRR promoter and further downregulates FENDRR, a long intergenic non-coding RNA (lincRNA) that functions to inhibit lung cancer by affecting expressions of an abundant number of genes, including the tumor suppressor positive regulation of transcription, DNA-templated.">
		<entity id="s4.e1" charOffset="66-117"
			type="GO" text="positive regulation of transcription, DNA-templated" ontology_id="GO_0045893"/>
		<entity id="s4.e2" charOffset="409-415"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s4.e3" charOffset="487-492"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e3" pgr="false"/>
		<pair id="s4.p2" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
	</sentence>
	<sentence id="s5" text="These findings suggested the CNVR_3425.1 to be a possibly predictive biomarker for the risk of lung cancer and ER to Golgi vesicle-mediated transport, and targeted molecular therapy pertaining to FENDRR upregulation may be a valuable pathway to fight two diseases">
		<entity id="s5.e1" charOffset="100-106"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s5.e2" charOffset="111-149"
			type="GO" text="ER to Golgi vesicle-mediated transport" ontology_id="GO_0006888"/>
		<pair id="s5.p1" e1="s5.e1"
		    e2="s5.e2" pgr="false"/>
	</sentence>
</document>
